Original Source(s)
Related Content
FDA Okays Weekly Option in Achondroplasia
Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.
March 2, 2026
-
2 min
AI Scribes Lag Clinicians on Note Quality
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
by Kerri Miller
April 17, 2026
-
6 min
Palatal Expansion Linked to Better Hearing
Orthodontic expansion shows hearing gains comparable to surgical treatment in selected patients
April 30, 2026
-
3 min
